Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation

Explore clinical trials studying Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation trial results

Completed

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

NCT02752035

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Hematologic Diseases, +6 more
Locations
  • UCLA David Geffen School of Medicine Los Angeles, California, United States
  • University of California, Irvine Medical Center Orange, California, United States
  • Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 111 locations
View Trial Details
Completed

A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

NCT04691648

Conditions
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Site KR82013 Wŏnju, Gangwon-do, South Korea
  • Site KR82006 Goyang-si, Gyeonggi-do, South Korea
  • Site KR82003 Jeollanam-do, Hwasun-gun, South Korea
  • Site KR82011 Busan, South Korea
View Trial Details
Completed

A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML)

NCT03730012

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation, Hematologic Diseases, +6 more
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky Lexington, Kentucky, United States
View Trial Details

Related conditions